Levoleucovorin 175 MG Injection [Khapzory] — RxCUI 2106373
RxNorm drug concept · Semantic branded drug
RxCUI 2106373
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2106373
Official nameLevoleucovorin 175 MG Injection [Khapzory]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asKhapzory 175 MG Injection
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)155 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Levoleucovorin Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Great question. Levoleucovorin is not a chemotherapy drug on its own — it's actually a form of folate, similar to a B-vitamin. Depending on why you're receiving it, it's either pro...
- Why am I getting levoleucovorin — is it a chemotherapy drug itself?
- Nausea, vomiting, mouth sores, and diarrhea are the most commonly reported side effects — especially when levoleucovorin is given with 5-fluorouracil. Mild discomfort is expected,...
- What side effects should I expect, and which ones mean I need to call someone right away?
🕸️ Concept Web — How Levoleucovorin 175 MG Injection [Khapzory] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Levoleucovorin 175 MG Injection [Khapzory]
RxCUI 2106373 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Levoleucovorin
877015IN
-
Levoleucovorin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Khapzory
2106369BN
-
Khapzory
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Levoleucovorin Injection
1720759SCDF -
Levoleucovorin Injectable Product
1163207SCDG -
Levoleucovorin Injection [Khapzory]
2106371SBDF -
Khapzory Injectable Product
2106372SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Levoleucovorin Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Levoleucovorin 175 MG Injection
1858561SCD -
Levoleucovorin 175 MG
1858560SCDC -
Levoleucovorin 175 MG [Khapzory]
2106370SBDC
-
Levoleucovorin 175 MG Injection
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Levoleucovorin 175 MG Injection
SCD · 1858561 -
Levoleucovorin 175 MG
SCDC · 1858560 -
Levoleucovorin Injection
SCDF · 1720759 -
Levoleucovorin Injectable Product
SCDG · 1163207
Brand-Name Concepts
-
Levoleucovorin 175 MG [Khapzory]
SBDC · 2106370 -
Levoleucovorin Injection [Khapzory]
SBDF · 2106371 -
Khapzory Injectable Product
SBDG · 2106372 -
Khapzory
BN · 2106369
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2106373 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 72893-0004-01 | 1 VIAL in 1 CARTON (72893-004-01) / 3.5 mL in 1 VIAL | KHAPZORY | Acrotech Biopharma Inc | 2019-01-02 |
Observed labelers:
Acrotech Biopharma Inc (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J0642 | Injection, khapzory, 0.5 mg | 1 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.